About Sartorius Aktiengesellschaft (SRT3)
Sartorius Aktiengesellschaft is a Medical Instruments & Supplies company operating in the Healthcare sector.
SRT3 trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap stock .
Key Statistics
- Current Price
- €291.80
- Market Cap
- €20.15B
- 52-Week High
- €299.30
- 52-Week Low
- €198.50
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
€1,000 Invested in Sartorius Aktiengesellschaft (SRT3)
How much would €1,000 invested in SRT3 be worth today?
What would €1,000 invested in SRT3 1 year ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2025 would be worth €1,230 as of November 2026, representing a +23.0% total return.
What would €1,000 invested in SRT3 3 years ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2023 would be worth €1,246 as of November 2026, representing a +24.6% total return.
What would €1,000 invested in SRT3 5 years ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2021 would be worth €529 as of November 2026, representing a -47.1% total return.
What would €1,000 invested in SRT3 10 years ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2016 would be worth €4,213 as of November 2026, representing a +321.3% total return.
What would €1,000 invested in SRT3 at IPO be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) at IPO would be worth €293,083 as of November 2026, representing a +29208.3% total return.
Monthly Returns Heatmap
Over the past 27+ years (330 months), Sartorius Aktiengesellschaft (SRT3) has averaged a monthly return of +2.32% with a median return of +2.00%. The stock had 193 positive months (58%) and 135 negative months (41%). The best month in SRT3's history was April 2004 with a +41.5% return, while the worst was October 2008 at -47.6%. Historically, February tends to be the strongest month (averaging +4.8%), and September the weakest (-3.1%).
SRT3's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2004 with a cumulative return of +98.3%, and the worst was 2008 at -89.6%.
Annual Returns
Over 27 years of trading history, Sartorius Aktiengesellschaft (SRT3) has delivered an average annual return of +35.26% with a median return of +30.39%. The compound annual growth rate (CAGR) is +23.00%. The stock posted gains in 20 years (74%) and losses in 7 years (26%).
SRT3's best year was 2015 with a +139.57% gain, while the worst was 2008 at -68.92%. The longest streak of consecutive positive years was 13, and the longest losing streak was 3 years. SRT3 achieved double-digit gains (10%+) in 20 years. It suffered double-digit losses in 6 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +18.45% | €246.35 | €291.80 |
| 2025 | +15.25% | €213.75 | €246.35 |
| 2024 | -35.28% | €330.28 | €213.75 |
| 2023 | -9.48% | €364.86 | €330.28 |
| 2022 | -37.74% | €585.99 | €364.86 |
| 2021 | +73.51% | €337.73 | €585.99 |
| 2020 | +80.30% | €187.31 | €337.73 |
| 2019 | +75.92% | €106.47 | €187.31 |
| 2018 | +37.51% | €77.43 | €106.47 |
| 2017 | +13.47% | €68.24 | €77.43 |
| 2016 | +18.06% | €57.80 | €68.24 |
| 2015 | +139.57% | €24.13 | €57.80 |
| 2014 | +18.22% | €20.41 | €24.13 |
| 2013 | +30.39% | €15.65 | €20.41 |
| 2012 | +92.65% | €8.12 | €15.65 |
| 2011 | +31.69% | €6.17 | €8.12 |
| 2010 | +76.18% | €3.50 | €6.17 |
| 2009 | +106.92% | €1.69 | €3.50 |
| 2008 | -68.92% | €5.44 | €1.69 |
| 2007 | -16.90% | €6.55 | €5.44 |
| 2006 | +63.96% | €4.00 | €6.55 |
| 2005 | +37.79% | €2.90 | €4.00 |
| 2004 | +131.51% | €1.25 | €2.90 |
| 2003 | +91.62% | €0.65 | €1.25 |
| 2002 | -45.34% | €1.20 | €0.65 |
| 2001 | -12.22% | €1.36 | €1.20 |
| 2000 | +24.99% | €1.09 | €1.36 |
Frequently Asked Questions: SRT3
What sector is SRT3 in? ▼
SRT3 operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SRT3 performed historically? ▼
Over 27 years of trading history, SRT3 has posted gains in 20 years (74% of the time). The best year was 2015 with a +139.6% return. Past performance does not guarantee future results.
How can I invest in SRT3? ▼
You can invest in SRT3 through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SRT3.
Last updated: 11/1/2026